Cargando…
Design and Discovery of Quinazoline- and Thiourea-Containing Sorafenib Analogs as EGFR and VEGFR-2 Dual TK Inhibitors
Both EGFR and VEGFR-2 play a critical role in tumor growth, angiogenesis and metastasis, and targeting EGFR and VEGFR-2 simultaneously represents a promising approach to cancer treatment. In this work, a series of novel quinazoline- and thiourea-containing sorafenib analogs (10a–v) were designed and...
Autores principales: | Sun, Shaofeng, Zhang, Jingwen, Wang, Ningning, Kong, Xiangkai, Fu, Fenghua, Wang, Hongbo, Yao, Jianwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943947/ https://www.ncbi.nlm.nih.gov/pubmed/29295519 http://dx.doi.org/10.3390/molecules23010024 |
Ejemplares similares
-
Novel Anticancer Fused Pyrazole Derivatives as EGFR and VEGFR-2 Dual TK Inhibitors
por: Saleh, Nashwa M., et al.
Publicado: (2020) -
Design and biological evaluation of 3-substituted quinazoline-2,4(1H,3H)-dione derivatives as dual c-Met/VEGFR-2-TK inhibitors
por: Hassan, Abdelfattah, et al.
Publicado: (2023) -
Discovery of a series of novel phenylpiperazine derivatives as EGFR TK inhibitors
por: Sun, Juan, et al.
Publicado: (2015) -
Discovery of novel quinazoline derivatives bearing semicarbazone moiety as potent EGFR kinase inhibitors
por: Tu, Yuanbiao, et al.
Publicado: (2018) -
NSK-01105, a Novel Sorafenib Derivative, Inhibits Human Prostate Tumor Growth via Suppression of VEGFR2/EGFR-Mediated Angiogenesis
por: Yu, Pengfei, et al.
Publicado: (2014)